These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27624903)

  • 1. [Study results of primary therapy for head and neck tumors : Highlights of the 2016 ASCO Annual Meeting].
    Gliese A; Busch CJ; Knecht R
    HNO; 2016 Oct; 64(10):717-22. PubMed ID: 27624903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of head and neck squamous cell carcinoma recurrences and distant metastases : Highlights of the ASCO Meeting 2016].
    Bußmann L; Busch CJ; Knecht R
    HNO; 2016 Oct; 64(10):723-30. PubMed ID: 27604281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Main results of studies on primary therapy of head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2014].
    Gliese A; Busch CJ; Knecht R
    HNO; 2014 Nov; 62(11):781-6. PubMed ID: 25274201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotherapeutic studies of head and neck tumors : Highlights of the 2016 ASCO Annual Meeting].
    Busch CJ; Laban S; Knecht R; Hoffmann TK
    HNO; 2016 Oct; 64(10):708-16. PubMed ID: 27604282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy for HNSCC : Quo vadis?].
    Döscher J; Busch CJ; Schuler PJ; Laban S
    HNO; 2016 Oct; 64(10):700-7. PubMed ID: 27624904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The most important study results concerning nonsurgical primary treatment of locally advanced head and neck cancer: Highlights of the ASCO Meeting 2015].
    Gliese A; Busch CJ; Knecht R
    HNO; 2015 Sep; 63(9):606-11. PubMed ID: 26303521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The most important study results of primary chemoradiation for head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2013].
    Münscher A; Busch CJ; Schafhausen P; Tribius S; Knecht R
    HNO; 2013 Nov; 61(11):905-10. PubMed ID: 24221218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy of head and neck tumors: Highlights of the ASCO Meeting 2015].
    Laban S; Doescher J; Schuler PJ; Bullinger L; Brunner C; Veit JA; Hoffmann TK
    HNO; 2015 Sep; 63(9):612-9. PubMed ID: 26319429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Treatment Options in Head and Neck Cancer.
    Schuler PJ; Laban S; Doescher J; Bullinger L; Hoffmann TK
    Oncol Res Treat; 2017; 40(6):342-346. PubMed ID: 28521322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of recurrent or metastatic head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2014].
    Zeller N; Busch CJ; Schafhausen P; Knecht R; Möckelmann N
    HNO; 2014 Nov; 62(11):787-92. PubMed ID: 25298331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Treatment for Squamous Cell Carcinoma of the Head and Neck.
    Shetty AV; Wong DJ
    Otolaryngol Clin North Am; 2017 Aug; 50(4):775-782. PubMed ID: 28755705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New aspects in the treatment of thyroid cancer : Highlights of the ASCO Annual Meeting 2016].
    Lörincz BB; Simon C; Möckelmann N; Knecht R
    HNO; 2016 Oct; 64(10):736-40. PubMed ID: 27624902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The most important results on primary chemoradiation for head and neck squamous cell carcinoma: highlights from the 2012 ASCO meeting].
    Laban S; Zielinski V; Busch CJ; Münscher A; Schafhausen P; Tribius S; Knecht R
    HNO; 2012 Nov; 60(11):962-7. PubMed ID: 23114542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiotherapeutic studies of head and neck cancer-highlights of the 2018 ASCO Annual Meeting].
    Ott S; Wiegel T; Laban S; Hoffmann TK; Petersen C; Tribius S
    HNO; 2018 Dec; 66(12):901-906. PubMed ID: 30421001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular targeted therapies in the management of head and neck squamous cell carcinoma: recent developments and perspectives.
    Bozec A; Peyrade F; Milano G
    Anticancer Agents Med Chem; 2013 Mar; 13(3):389-402. PubMed ID: 23092267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunomodulation as innovative therapy for head and neck tumors : Current developments].
    Schuler PJ; Doescher JC; Laban S; Hoffmann TK
    HNO; 2016 Jul; 64(7):470-8. PubMed ID: 26912050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab.
    Baxi SS; O'Neill C; Sherman EJ; Atoria CL; Lee NY; Pfister DG; Elkin EB
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E165-71. PubMed ID: 25535104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curative treatment of head and neck squamous cell carcinoma : Organ preservation strategies in clinical routine in German-speaking countries.
    Kurzweg T; Kimmeyer J; Knecht R; Hoffmann TK; Busch CJ; Lörincz BB; Schuler PJ; Laban S
    HNO; 2016 Jul; 64(7):501-7. PubMed ID: 27357174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy in locally advanced head and neck squamous cell carcinoma.
    Gyawali B; Shimokata T; Honda K; Ando Y
    Cancer Treat Rev; 2016 Mar; 44():10-6. PubMed ID: 26924194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for Head and Neck Squamous Cell Carcinoma.
    Schoppy DW; Sunwoo JB
    Hematol Oncol Clin North Am; 2015 Dec; 29(6):1033-43. PubMed ID: 26568546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.